Virusight has developed an AI-powered diagnostic platform that utilizes the SpectraLIT® device to deliver non-invasive pathogen detection results in under 20 seconds with 96.3% accuracy. This technology addresses the urgent need for rapid and reliable disease diagnosis, enabling real-time infection control in various environments such as healthcare, travel, and education.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for pathogen detection often require laboratory analysis, resulting in delays in diagnosis and hindering real-time infection control. Traditional testing methods can also be invasive and costly, limiting their accessibility for mass screening and point-of-care applications.
Solution
Virusight Diagnostic offers a rapid diagnostic platform leveraging the SpectraLIT device, which uses spectral analysis and AI to detect pathogens non-invasively in under 20 seconds. The system analyzes samples obtained from mouth swabs using machine-learning algorithms to identify SARS-CoV-2 and other pathogens. Results are delivered instantly to a connected device, enabling immediate action to control infection spread. The portable and user-friendly design of SpectraLIT facilitates deployment in various settings, including healthcare facilities, travel hubs, and educational institutions, providing a scalable solution for real-time disease diagnosis.
Target Audience
The primary target audience includes healthcare providers, travel and tourism industries, educational institutions, and other organizations requiring rapid and accurate pathogen detection for infection control and prevention.
Features
- Non-invasive sample collection via mouth swab
- Rapid spectral analysis powered by the SpectraLIT device
- AI-driven pathogen detection algorithms for accurate identification
- Results delivered in under 20 seconds to a connected device
- Portable and easy-to-use design for point-of-care testing
- Cloud-based software for real-time monitoring and data analysis
- CE marked for the European market